Author:
Kaur Jasleen,Deshmukh Prasad T,Gaurkar Sagar S
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Tuberculosis: epidemiology and control;Sulis G;Mediterr J Hematol Infect Dis,2014
2. Tuberculosis. multidrug-resistant (MDR-TB) or rifampicin-resistant TB (RR-TB). (2023). Accessed: July 3, 2024: https://www.who.int/news-room/questions-and-answers/item/tuberculosis-multidrug-resistant-tuberculosis-.
3. Some manifestations of tuberculosis in otorhinolaryngology - case series and a short review of related data from South-Eastern Europe;Mocanu AI;Infect Drug Resist,2022
4. ENT manifestations of tuberculosis: an important aspect of ENT practice;Sharma S;Pan Afr Med J,2020
5. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling;Houben RM;PLoS Med,2016